The Board of Mochida Pharmaceutical Co., Ltd. has authorized a buyback plan on August 1, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3,170 JPY | -1.86% | -1.09% | -3.06% |
04-25 | Hidehiro Imatsu named president of Goldman Sachs Japan | RE |
03-21 | Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.06% | 735M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- 4534 Stock
- News Mochida Pharmaceutical Co., Ltd.
- Mochida Pharmaceutical Co., Ltd. authorizes a Buyback Plan.